- Home
- KTTA vs NDRA Comparison
KTTA vs NDRA Comparison
Compare KTTA & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- NDRA
- Stock Information
- Founded
- KTTA 2020
- NDRA 2007
- Country
- KTTA United States
- NDRA United States
- Employees
- KTTA N/A
- NDRA N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KTTA Health Care
- NDRA Health Care
- Exchange
- KTTA Nasdaq
- NDRA Nasdaq
- Market Cap
- KTTA 2.8M
- NDRA 2.3M
- IPO Year
- KTTA 2021
- NDRA 2017
- Fundamental
- Price
- KTTA $0.73
- NDRA $3.52
- Analyst Decision
- KTTA
- NDRA Strong Buy
- Analyst Count
- KTTA 0
- NDRA 1
- Target Price
- KTTA N/A
- NDRA $46.00
- AVG Volume (30 Days)
- KTTA 192.8K
- NDRA 29.5K
- Earning Date
- KTTA 08-12-2025
- NDRA 08-13-2025
- Dividend Yield
- KTTA N/A
- NDRA N/A
- EPS Growth
- KTTA N/A
- NDRA N/A
- EPS
- KTTA N/A
- NDRA N/A
- Revenue
- KTTA N/A
- NDRA N/A
- Revenue This Year
- KTTA N/A
- NDRA N/A
- Revenue Next Year
- KTTA N/A
- NDRA N/A
- P/E Ratio
- KTTA N/A
- NDRA N/A
- Revenue Growth
- KTTA N/A
- NDRA N/A
- 52 Week Low
- KTTA $0.70
- NDRA $2.90
- 52 Week High
- KTTA $7.50
- NDRA $179.20
- Technical
- Relative Strength Index (RSI)
- KTTA 35.02
- NDRA 50.31
- Support Level
- KTTA $0.70
- NDRA $3.41
- Resistance Level
- KTTA $0.76
- NDRA $3.59
- Average True Range (ATR)
- KTTA 0.04
- NDRA 0.18
- MACD
- KTTA 0.01
- NDRA 0.05
- Stochastic Oscillator
- KTTA 13.68
- NDRA 62.30
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.